About: Saratoga Opthalmology

Posts by Saratoga Opthalmology:

Autologous retinal transplant appears promising for persistent macular hole

Investigators retrospectively report the structural and functional outcomes of autologous neurosensory retinal transplant for refractory large macular holes. Source: AAO

Posted on: Mar 4 2019
By: Saratoga Opthalmology
Leave a reponse

Week in review: Spark deal, salary survey, 1 in a million

This week, Roche plans to acquire Spark Therapeutics for $4.3 billion, MedPage ranks ophthalmologists’ salaries 15th among 25 specialties and a mouse model accelerates research on a rare retinal disease. Source: AAO

Posted on: Mar 1 2019
By: Saratoga Opthalmology
Leave a reponse

Is complete fluid resolution necessary in patients with choroidal neovascularization secondary to AMD?

Investigators compared visual acuity in patients with neovascular AMD tolerating some subretinal fluid (SRF) with those undergoing treatment to resolve all SRF. Source: AAO

Posted on: Mar 1 2019
By: Saratoga Opthalmology
Leave a reponse

Topical chemotherapy agents similarly effective against ocular surface squamous neoplasia

This study compared the effectiveness of topical 5-fluorouracil 1% (5FU) versus interferon alfa-2b eye drops as primary treatment modalities for ocular surface squamous neoplasia. Source: AAO

Posted on: Feb 28 2019
By: Saratoga Opthalmology
Leave a reponse

Symptomatic treatment sufficient for most meningiomas of the cavernous sinus

This study describes the natural history of meningiomas confined to the cavernous sinus (MCSs) to better inform the choice of treatment. Source: AAO

Posted on: Feb 27 2019
By: Saratoga Opthalmology
Leave a reponse

New loteprednol formulation approved for postop inflammation, pain management

Bausch + Lomb’s new formulation of loteprednol etabonate ophthalmic gel, Lotemax SM 0.38%, has been cleared by the FDA for postoperative pain and inflammation. Source: AAO

Posted on: Feb 27 2019
By: Saratoga Opthalmology
Leave a reponse

Vascular abnormalities common following intravitreal bevacizumab for ROP

Researchers report the regression patterns experienced by patients after off-label intravitreal bevacizumab therapy for retinopathy of prematurity (ROP). Source: AAO

Posted on: Feb 26 2019
By: Saratoga Opthalmology
Leave a reponse

Trial underway to study safety of retinal gene therapy for dry AMD

Last week, an 80-year-old Oxford woman became the first person to receive an experimental retinal gene therapy for dry AMD. Source: AAO

Posted on: Feb 26 2019
By: Saratoga Opthalmology
Leave a reponse

Exfoliation syndrome linked to increased risk of COPD

In this study, investigators evaluated the potential association between exfoliation syndrome and chronic obstructive pulmonary disease (COPD). Source: AAO